Archive correction — 14 October 2026. The earlier article described a nationwide vendor-consolidation trend without supporting evidence for its tool counts, failure rates or savings. Those claims have been removed. This version is a procurement checklist, not original market research or a claim of firsthand enterprise audits. Original publication dates are retained.
Start with your own inventory
ObvioTech recommendation: list the AI tools actually used by your organisation, including subscriptions bought by individual teams. Record the owner, purpose, users, data handled, cost, renewal date and relevant connections. Avoid starting from a claim that a typical UK enterprise has a particular number of tools; that number would not establish your own requirements.
A larger portfolio can contain overlap, but a smaller portfolio is not automatically safer or cheaper. Consolidation can create dependencies, migration work and a single point of failure. Evaluate the trade-off for the actual workflows.
What an evidence-based review can measure
- Use: how often is the tool used for an authorised task, and by whom?
- Result: what measurable improvement has been observed after review and correction costs?
- Overlap: can another tool perform the same task at an acceptable quality and total cost?
- Integration: what breaks if the tool is removed, and which data must be retained or exported?
- Governance: are responsibilities, access, vendor terms and data flows documented?
Set criteria before scoring products. There is no evidence here for a universal rule to remove every tool that fails two criteria, or a fixed target of fifteen vendors. A specialist tool may be justified by a requirement that a broader platform cannot meet.
Check data use rather than relying on vendor size
The ICO provides guidance for organisations applying data protection law to AI. The actual use of personal data and the organisation’s responsibilities matter; a large vendor’s reputation does not settle whether a particular deployment is appropriate. ICO AI guidance.
ObvioTech recommendation: review what is sent to the provider, retention and reuse terms, permissions, subprocessors, deletion and exit arrangements, and the checks needed for the proposed output. A tool being approved internally is not a legal certification. Smaller providers are not inherently non-compliant, and larger providers are not inherently low risk.
Test a change before cancelling a dependency
Compare representative tasks in the proposed replacement. Include uncommon but important failures, accessibility needs, human review and recovery. Record what was tested and what was not. Preserve necessary information and confirm that affected teams can continue working before removing access.
ObvioTech recommendation: a review should be able to conclude keep, replace, reduce, renegotiate or investigate further. The purpose is to improve the actual workflow, not to force a predetermined reduction in subscriptions.
Keep conclusions bounded
This checklist does not establish a nationwide 2026 buying pattern, a twelve-to-eighteen-month propagation rule between industries, or guaranteed savings from consolidation. Claims about a wider market require a dated sample and method. Decisions about your organisation should rest on its evidence and applicable obligations.
